Brief: HCW Biologics reports Q2 results
12/08/2022 12:06
Aug 12 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND
RECENT BUSINESS HIGHLIGHTS
* HCW BIOLOGICS - SEES CURRENT CASH BALANCE, COMMITMENT FOR
TERM
FACILITY FOR PURCHASE OF NEW HEADQUARTERS, SUFFICIENT TO FUND
OPERATIONS, CAPEX THROUGH 2023 END
* HCW BIOLOGICS INC QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED
$0.10
Source text for Eikon: ID:nGNX6cL12R
Further company coverage: HCWB.O
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM